| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.16B | +65.0% |
| Gross Profit | $285.2M | +51.2% |
| R&D Expense | $9.8M | +149.5% |
| SG&A Expense | $73.9M | +146.4% |
| Operating Income | $130.6M | +18.7% |
| Pre-tax Income | $140.6M | +22.3% |
| Income Tax | $14.8M | -29.1% |
| Net Income | $125.8M | +33.7% |
| EPS (Basic) | $3.06 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $259.8M | +41.7% |
| Short-term Investments | $42.7M | — |
| Accounts Receivable | $57.3M | -2.7% |
| Inventory | $172.5M | +30.4% |
| Current Assets | $547.6M | +39.4% |
| Total Assets | $1.07B | +26.4% |
| Current Liabilities | $264.4M | +28.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $158.1M | +18.5% |
| Capital Expenditures | $15.5M | +254.7% |
| Investing Cash Flow | -$55.4M | +38.8% |
| Financing Cash Flow | -$25.0M | -523.8% |
| Free Cash Flow | $142.5M | +10.4% |
| +32.5% |
| EPS (Diluted) | $3.05 | +32.6% |
| Total Liabilities |
| $665.3M |
| +19.5% |
| Stockholders' Equity | $405.2M | +39.5% |